Sen. Collins Applauds Partnership to Make Low-Cost Insulin Available to All Americans
March 04, 2022
March 04, 2022
WASHINGTON, March 4 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
U.S. Senator Susan Collins, the founder and co-chair of the Senate Diabetes Caucus and a member of the Senate Health Committee, released the following statement upon the announcement of the production of low-cost biosimilar insulin for U.S. patients.
This low-cost insulin, which will have a recommended price of no more than $30 per vial and no more than $55 per box of five pen cart . . .
U.S. Senator Susan Collins, the founder and co-chair of the Senate Diabetes Caucus and a member of the Senate Health Committee, released the following statement upon the announcement of the production of low-cost biosimilar insulin for U.S. patients.
This low-cost insulin, which will have a recommended price of no more than $30 per vial and no more than $55 per box of five pen cart . . .